Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells

Sarah E. Williford, Catherine J. Libby, Adetokunbo Ayokanmbi, Arphaxad Otamias, Juan J. Gordillo, Emily R. Gordon, Sara J. Cooper, Matthew Redmann, Yanjie Li, Corinne Griguer, Jianhua Zhang, Marek Napierala, Subramaniam Ananthan, Anita B. Hjelmeland

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences